American Gene Technologies, a clinical stage biotech based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development.
American Gene Technologies is a gene therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Dr. Wells joined the company’s investor relations team in 2019.
After nearly four decades as a urologist and surgeon treating patients suffering from perirenal abscess, kidney stones, urinary tract infection and other urological issues, he has broadened his scope to help American Gene Technologies in its mission to use the power of gene therapy to relieve human suffering from serious diseases.
In addition to medicine, Dr. Wells has also long been interested in business and technology. He formed two small-business ventures and has raised funds for New Sapience, an AI company in its early stage of growth.
Dr. Wells earned his bachelor of arts degree in 1977 at the University of Kansas, where his academic achievement led to his election to Phi Beta Kappa. He graduated from the Kansas University School of Medicine with his M.D. in 1983. He completed a residency in urologic surgery at University of Maryland Medical Center from 1983 to 1988.